Journal article
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update
Abstract
PURPOSE: To update recommendations of the American Society of Clinical Oncology (ASCO)-Ontario Health (Cancer Care Ontario [CCO]) adjuvant bone-modifying agents in breast cancer guideline.
METHODS: An Expert Panel conducted a systematic review to identify new, potentially practice-changing data.
Authors
Eisen A; Somerfield MR; Accordino MK; Blanchette PS; Clemons MJ; Dhesy-Thind S; Dillmon MS; D'Oronzo S; Fletcher GG; Frank ES
Journal
Journal of Clinical Oncology, Vol. 40, No. 7, pp. 787–800
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2022
DOI
10.1200/jco.21.02647
ISSN
0732-183X